Financials in GBp. Standardized financial statements.
A compact view of how Destiny Pharma plc turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £831,552 | £154,499 | £135,028 | £12,450 | £305,906 | £0 | £0 | £0 | £0 | £0 |
| Revenue Growth? | +438.2% | +14.4% | +984.6% | -95.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | £6,196 | £12,328 | £12,518 | £16,881 | £18,440 | £9,663 | £2,077 | £1,339 | £0 | £0 |
| Gross Profit? | £825,356 | £142,171 | £122,510 | -£4,431 | £287,466 | -£9,663 | -£2,077 | -£1,339 | £0 | £0 |
| Gross Margin? | +99.3% | +92.0% | +90.7% | -35.6% | +94.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | £7.40M | £7.87M | £6.42M | £6.54M | £5.83M | £6.20M | £2.72M | £1.45M | £1.20M | £2.08M |
| Operating Income? | -£6.57M | -£7.89M | -£6.43M | -£6.55M | -£5.84M | -£6.21M | -£2.72M | -£1.45M | -£1.20M | -£2.08M |
| EBITDA? | -£6.56M | -£7.76M | -£6.27M | -£6.54M | -£5.83M | -£6.20M | -£2.72M | -£1.45M | -£1.20M | -£2.07M |
| Income Before Tax | -£6.45M | -£7.71M | -£6.27M | -£6.48M | -£5.52M | -£6.01M | -£3.21M | -£1.45M | -£1.20M | -£2.07M |
| Income Tax Expense | -£789,202 | -£1.21M | -£931,951 | -£1.07M | -£813,250 | -£841,144 | -£233,908 | -£191,578 | -£181,932 | -£303,276 |
| Net Income? | -£5.66M | -£6.50M | -£5.34M | -£5.41M | -£4.71M | -£5.17M | -£2.98M | -£1.26M | -£1.02M | -£1.76M |
| EPS? | £-0.06 | £-0.09 | £-0.09 | £-0.12 | £-0.11 | £-0.12 | £-0.08 | £-0.03 | £-0.02 | £-0.04 |
| Diluted EPS? | £-0.06 | £-0.09 | £-0.09 | £-0.12 | £-0.11 | £-0.12 | £-0.08 | £-0.03 | £-0.02 | £-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality